Carlos Góis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Carlos Góis has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
- Diogo Frasquilho Guerreiro
Psychiatry Department, Faculty of Medicine, University of Lisbon, Lisbon, Portugal
3 shared publications Hagop Akiskal
3 shared publications- Isabel Do Carmo
Department of Endocrinology, Hospital de Santa Maria, Lisboa
3 shared publications Kareen Akiskal
3 shared publicationsM. Luisa Figueira
3 shared publicationsMaria Luísa Figueira
Faculdade de Medicina, Universidade de Lisboa, Av. Prof. Egas Moniz, 1649-028 Lisboa, Portugal
3 shared publications
Latest Publications
- Open Access
- 20 July 2026
- Published by Springer Nature in Archives of Women's Mental Health
- Vol. 29 (4) , 110
The efficacy of antidepressant medication versus interpersonal psychotherapy for depression in middle-aged women: a systematic review and individual participant data meta-analysis
Purpose: Depression is highly prevalent in middle-aged women (MAW), but head-to-head comparisons of first-line interventions in this population are scarce. This systematic review and individual participant data (IPD) meta-analysis examined the comparative efficacy of antidepressant medication (ADM) and interpersonal psychotherapy (IPT) for MAW (aged 40–64) versus other adults (men and non-MAW) on depression, quality of life, and interpersonal problem measures. Methods: PubMed, PsycINFO, Embase, and the Cochrane Library were searched January 1, 2025 to identify randomized trials comparing ADM and IPT for adults with depression. IPD were requested and analyzed using mixed-effects models. Results: IPD were obtained from 9 of the 15 (60%) identified studies, comprising 1,490 participants (527 MAW, 963 other adults). MAW status did not significantly moderate ADM versus IPT comparative efficacy on depression ( p = .10) and interpersonal problems ( p = .29) outcomes. The two treatments did not significantly differ in treatment effect in the MAW group (depression: b = -0.03, p = .76; interpersonal problems: b = -0.20, p = .31). MAW status significantly moderated comparative efficacy on quality of life measures ( b = 0.37, p = .02). Whereas IPT was non-significantly more efficacious than ADM for MAW ( b = -0.18, p = .15), ADM were non-significantly more efficacious than IPT for other adults ( b = 0.19, p = .051). Conclusion: This is the first IPD meta-analysis directly comparing depression treatments in MAW. The absence of treatment effect differences indicates that other factors (e.g., patient preference) may guide choice between IPT and ADM in this population.
- 20 July 2026
- Published by Springer Nature in Archives of Women's Mental Health
- Vol. 29 (4) , 110
Open AccessThe efficacy of antidepressant medication versus interpersonal psychotherapy for depression in middle-aged women: a systematic review and individual participant data meta-analysis
Purpose: Depression is highly prevalent in middle-aged women (MAW), but head-to-head comparisons of first-line interventions in this population are scarce. This systematic review and individual participant data (IPD) meta-analysis examined the comparative efficacy of antidepressant medication (ADM) and interpersonal psychotherapy (IPT) for MAW (aged 40–64) versus other adults (men and non-MAW) on depression, quality of life, and interpersonal problem measures. Methods: PubMed, PsycINFO, Embase, and the Cochrane Library were searched January 1, 2025 to identify randomized trials comparing ADM and IPT for adults with depression. IPD were requested and analyzed using mixed-effects models. Results: IPD were obtained from 9 of the 15 (60%) identified studies, comprising 1,490 participants (527 MAW, 963 other adults). MAW status did not significantly moderate ADM versus IPT comparative efficacy on depression ( p = .10) and interpersonal problems ( p = .29) outcomes. The two treatments did not significantly differ in treatment effect in the MAW group (depression: b = -0.03, p = .76; interpersonal problems: b = -0.20, p = .31). MAW status significantly moderated comparative efficacy on quality of life measures ( b = 0.37, p = .02). Whereas IPT was non-significantly more efficacious than ADM for MAW ( b = -0.18, p = .15), ADM were non-significantly more efficacious than IPT for other adults ( b = 0.19, p = .051). Conclusion: This is the first IPD meta-analysis directly comparing depression treatments in MAW. The absence of treatment effect differences indicates that other factors (e.g., patient preference) may guide choice between IPT and ADM in this population.
- Open Access
- 1 November 2018
- Published by Taylor & Francis in Advances in Medical Education and Practice
- Vol. ume 9, 873-880
Suicidal ideation in medical students: recent insights
Background: Previous studies have indicated that suicidal ideation is prevalent in medical students. The factors related to school admission processes and medical school environments contribute to this high prevalence. The consequences of suicidal ideation include suicide attempts and completed suicide. This article reviewed the recent literature on suicidal ideation in medical students. Materials and methods: A systematic review of the literature was conducted to identify the articles published on the prevalence of suicidal ideation and associated factors in medical students. Original articles published from 2011 were included. Results: Seventeen studies comprising a total of 13,244 medical students from 13 Western and non-Western countries were included. The prevalence of suicidal ideation ranged from 1.8% to 53.6%. The most frequent factors associated with suicidal ideation in medical students were depression and depressive symptoms, a previous diagnosis of a psychiatric disorder, lower socioeconomic status/financial difficulties, having a history of drug use, and feeling neglected by parents. We did not find studies on interventional studies on suicidal ideation in medical students published in recent years. Conclusion: We identified a number of non-Western studies published in recent years, overcoming the previous scarcity of research in this area. Findings confirmed that suicidal ideation in medical students remains a significant concern. Future studies should focus on preventive and treatment programs targeting the identified factors associated with suicidal ideation in medical students.
- 1 November 2018
- Published by Taylor & Francis in Advances in Medical Education and Practice
- Vol. ume 9, 873-880
Open AccessSuicidal ideation in medical students: recent insights
Background: Previous studies have indicated that suicidal ideation is prevalent in medical students. The factors related to school admission processes and medical school environments contribute to this high prevalence. The consequences of suicidal ideation include suicide attempts and completed suicide. This article reviewed the recent literature on suicidal ideation in medical students. Materials and methods: A systematic review of the literature was conducted to identify the articles published on the prevalence of suicidal ideation and associated factors in medical students. Original articles published from 2011 were included. Results: Seventeen studies comprising a total of 13,244 medical students from 13 Western and non-Western countries were included. The prevalence of suicidal ideation ranged from 1.8% to 53.6%. The most frequent factors associated with suicidal ideation in medical students were depression and depressive symptoms, a previous diagnosis of a psychiatric disorder, lower socioeconomic status/financial difficulties, having a history of drug use, and feeling neglected by parents. We did not find studies on interventional studies on suicidal ideation in medical students published in recent years. Conclusion: We identified a number of non-Western studies published in recent years, overcoming the previous scarcity of research in this area. Findings confirmed that suicidal ideation in medical students remains a significant concern. Future studies should focus on preventive and treatment programs targeting the identified factors associated with suicidal ideation in medical students.
- Open Access
- 16 January 2018
- Published by Springer Nature in BMC Research Notes
- Vol. 11 (1) , 38
Depressive symptoms are associated with poor glycemic control among women with type 2 diabetes mellitus
In patients with type 2 diabetes mellitus, depressive symptoms may be associated with metabolic deterioration. The impact of sex on this association is unclear. The aim of this study is to analyze the relationship between depression and metabolic control by sex. The data presented is the side product of the clinical investigation by Rui Duarte, MD, Treatment Response in Type 2 Diabetes Patients with Major Depression from 2007. A sample of 628 outpatients with type 2 diabetes mellitus was taken from a specialized diabetes outpatient clinic. In a univariate analysis: women’s glycohemoglobin mean levels were 8.99% whereas men’s were 8.41% and the difference was statistically significant. The proportion of women (34.3%) with pathological levels of depression (Hospital Anxiety Depression Scale score ≥ 8) was significantly higher than men’s (15.2%). A linear regression analysis performed by sex and controlling for demographic, clinical and psychological variables, showed poorer metabolic control in women with depressive symptoms. No association was observed in men. These results support depression as a predictor for poor metabolic control in women and the need for detecting depressive symptoms when glycemic levels deteriorate.
- 16 January 2018
- Published by Springer Nature in BMC Research Notes
- Vol. 11 (1) , 38
Open AccessDepressive symptoms are associated with poor glycemic control among women with type 2 diabetes mellitus
In patients with type 2 diabetes mellitus, depressive symptoms may be associated with metabolic deterioration. The impact of sex on this association is unclear. The aim of this study is to analyze the relationship between depression and metabolic control by sex. The data presented is the side product of the clinical investigation by Rui Duarte, MD, Treatment Response in Type 2 Diabetes Patients with Major Depression from 2007. A sample of 628 outpatients with type 2 diabetes mellitus was taken from a specialized diabetes outpatient clinic. In a univariate analysis: women’s glycohemoglobin mean levels were 8.99% whereas men’s were 8.41% and the difference was statistically significant. The proportion of women (34.3%) with pathological levels of depression (Hospital Anxiety Depression Scale score ≥ 8) was significantly higher than men’s (15.2%). A linear regression analysis performed by sex and controlling for demographic, clinical and psychological variables, showed poorer metabolic control in women with depressive symptoms. No association was observed in men. These results support depression as a predictor for poor metabolic control in women and the need for detecting depressive symptoms when glycemic levels deteriorate.
- 1 July 2017
- Published by Elsevier in Psychiatry Research
- Vol. 253, 240-248
Depressive symptoms and suicidal behavior after first-episode psychosis: A comprehensive systematic review
- 1 July 2017
- Published by Elsevier in Psychiatry Research
- Vol. 253, 240-248
Depressive symptoms and suicidal behavior after first-episode psychosis: A comprehensive systematic review
- Open Access
- 10 November 2016
- Published by Sociedad Portuguesa de Psicologia da Saude in Psicologia, Saúde & Doença
- Vol. 17 (3) , 561-574
TOWARD A COGNITIVE-BEHAVIORAL INTERVENTION CULTURALLY ADAPTED: IMPLICATIONS FOR CLINICAL PRACTICE
- 10 November 2016
- Published by Sociedad Portuguesa de Psicologia da Saude in Psicologia, Saúde & Doença
- Vol. 17 (3) , 561-574
Open AccessTOWARD A COGNITIVE-BEHAVIORAL INTERVENTION CULTURALLY ADAPTED: IMPLICATIONS FOR CLINICAL PRACTICE
- 1 December 2012
- Published by Elsevier in Journal of Affective Disorders
- Vol. 143 (1-3) , 1-4
Depressive temperament, distress, psychological adjustment and depressive symptoms in type 2 diabetes
- 1 December 2012
- Published by Elsevier in Journal of Affective Disorders
- Vol. 143 (1-3) , 1-4
Depressive temperament, distress, psychological adjustment and depressive symptoms in type 2 diabetes
- 1 October 2012
- Published by Elsevier in Journal of Affective Disorders
- Vol. 142, S67-S71
The relationship between temperament, diabetes and depression
- 1 October 2012
- Published by Elsevier in Journal of Affective Disorders
- Vol. 142, S67-S71
The relationship between temperament, diabetes and depression
- 10 September 2012
- Published by Wiley in Clinical Psychology & Psychotherapy
- Vol. 21 (1) , 39-48
Treatment Response in Type 2 Diabetes Patients with Major Depression
Aims: Major depression is more prevalent in patients with type 2 diabetes mellitus (T2DM) than in general population. Comparing psychotherapeutic and pharmacological treatment responses could help to inform the choice between available treatment options.Method: Thirty‐four patients with T2DM and major depression detected by using the Hospital Anxiety‐Depression Scale (HADS), the Montgomery‐Äsberg Depression Rating Scale (MADRS) and a structured interview (Mini‐International Neuropsychiatric Interview) were randomized to undergo Interpersonal Psychotherapy (IPT) or treatment with sertraline in a 3‐month acute intervention course in addition to a 3‐month continuation format. Provided that the initial MADRS score was not reduced ≥25% at week 6, these early non‐responding patients continued treatment in a sequential add‐on combined format. Psychological adjustment to diabetes, attachment style, diabetes self‐efficacy, quality of life and HbA1c were also evaluated along intervention.Results: Out of 22 early‐responding patients (11 for each treatment type), 16 had clinically significant improvements (<50% initial MADRS score) at endpoint with 11 reaching remission (MADRS scores ≤8), and with no significant differences between IPT and sertraline. Within sequential add‐on treatment, out of eight patients, only three of them achieved a clinically significant improvement and only one reached remission.Conclusions: These preliminary results suggested that IPT may be an option to treat major depression in T2DM against medical care with sertraline. Early non‐responding patients likely need alternative or longer treatment interventions. Limitations of this study relate to small sample and absence of a control group, which was difficult to implement due to ethical restrictions. Copyright © 2012 John Wiley & Sons, Ltd.Key Practitioner Message: Findings suggest that Interpersonal Psychotherapy is a useful tool to treat major depression in type 2 diabetes patients. A significant number of type 2 diabetes patients with major depression do not achieve depression remission irrespective of the type of treatment. Further clinical research should focus on addictive effects of psychotherapy and psychopharmacology in the treatment of depressed patients with chronic somatic diseases.
- 10 September 2012
- Published by Wiley in Clinical Psychology & Psychotherapy
- Vol. 21 (1) , 39-48
Treatment Response in Type 2 Diabetes Patients with Major Depression
Aims: Major depression is more prevalent in patients with type 2 diabetes mellitus (T2DM) than in general population. Comparing psychotherapeutic and pharmacological treatment responses could help to inform the choice between available treatment options.Method: Thirty‐four patients with T2DM and major depression detected by using the Hospital Anxiety‐Depression Scale (HADS), the Montgomery‐Äsberg Depression Rating Scale (MADRS) and a structured interview (Mini‐International Neuropsychiatric Interview) were randomized to undergo Interpersonal Psychotherapy (IPT) or treatment with sertraline in a 3‐month acute intervention course in addition to a 3‐month continuation format. Provided that the initial MADRS score was not reduced ≥25% at week 6, these early non‐responding patients continued treatment in a sequential add‐on combined format. Psychological adjustment to diabetes, attachment style, diabetes self‐efficacy, quality of life and HbA1c were also evaluated along intervention.Results: Out of 22 early‐responding patients (11 for each treatment type), 16 had clinically significant improvements (<50% initial MADRS score) at endpoint with 11 reaching remission (MADRS scores ≤8), and with no significant differences between IPT and sertraline. Within sequential add‐on treatment, out of eight patients, only three of them achieved a clinically significant improvement and only one reached remission.Conclusions: These preliminary results suggested that IPT may be an option to treat major depression in T2DM against medical care with sertraline. Early non‐responding patients likely need alternative or longer treatment interventions. Limitations of this study relate to small sample and absence of a control group, which was difficult to implement due to ethical restrictions. Copyright © 2012 John Wiley & Sons, Ltd.Key Practitioner Message: Findings suggest that Interpersonal Psychotherapy is a useful tool to treat major depression in type 2 diabetes patients. A significant number of type 2 diabetes patients with major depression do not achieve depression remission irrespective of the type of treatment. Further clinical research should focus on addictive effects of psychotherapy and psychopharmacology in the treatment of depressed patients with chronic somatic diseases.
- Open Access
- 7 June 2012
- Published by Springer Nature in BMC Research Notes
- Vol. 5 (1) , 271
Vulnerability to stress, anxiety and depressive symptoms and metabolic control in Type 2 diabetes
Vulnerability to stress has been associated to distress, emotional distress symptoms and metabolic control in type 2 diabetes mellitus (T2DM) patients as well. Furthermore some conflicting results were noticed. We aimed to evaluate the effect over metabolic control in what concerns vulnerability to stress beyond depressive and anxiety symptoms. This cross-sectional study assessed 273 T2DM patients with depressive and anxiety symptoms using the Hospital Anxiety Depression Scale (HADS) and the 23 Questions to assess Vulnerability to Stress (23QVS), along with demographic and clinical diabetes-related variables. Hierarchical logistic regression models were used to investigate predictors of poor glycemic control. The results showed an association of depressive symptoms (odds ratio = 1.12, 95%CI = 1.01-1.24, P = 0.030) with increased risk of poor glycemic control. Anxiety symptoms and vulnerability to stress on their own were not predictive of metabolic control, respectively (odds ratio = 0.92, 95%CI = 0.84-1.00, P = 0.187 and odds ratio = 0.98, 95%CI = 0.95-1.01, P = 0.282). Our data suggested that vulnerability to stress was not predictive of poor glycemic control in T2DM, but depressive symptoms were.
- 7 June 2012
- Published by Springer Nature in BMC Research Notes
- Vol. 5 (1) , 271
Open AccessVulnerability to stress, anxiety and depressive symptoms and metabolic control in Type 2 diabetes
Vulnerability to stress has been associated to distress, emotional distress symptoms and metabolic control in type 2 diabetes mellitus (T2DM) patients as well. Furthermore some conflicting results were noticed. We aimed to evaluate the effect over metabolic control in what concerns vulnerability to stress beyond depressive and anxiety symptoms. This cross-sectional study assessed 273 T2DM patients with depressive and anxiety symptoms using the Hospital Anxiety Depression Scale (HADS) and the 23 Questions to assess Vulnerability to Stress (23QVS), along with demographic and clinical diabetes-related variables. Hierarchical logistic regression models were used to investigate predictors of poor glycemic control. The results showed an association of depressive symptoms (odds ratio = 1.12, 95%CI = 1.01-1.24, P = 0.030) with increased risk of poor glycemic control. Anxiety symptoms and vulnerability to stress on their own were not predictive of metabolic control, respectively (odds ratio = 0.92, 95%CI = 0.84-1.00, P = 0.187 and odds ratio = 0.98, 95%CI = 0.95-1.01, P = 0.282). Our data suggested that vulnerability to stress was not predictive of poor glycemic control in T2DM, but depressive symptoms were.
- 29 December 2011
- Vol. 24 (5) , 739-56
[Club drugs].
Club drugs are the following substances: Methylenedioxymethamphetamine (MDMA); Methamphetamine; Lysergic Acid Diethylamide (LSD); Ketamine; Gamma-hydroxybutyrate (GHB) and Flunitrazepam. These substances are mainly used by adolescents and young adults, mostly in recreational settings like dance clubs and rave parties. These drugs have diverse psychotropic effects, are associated with several degrees of toxicity, dependence and long term adverse effects. Some have been used for several decades, while others are relatively recent substances of abuse. They have distinct pharmacodynamic and pharmacokinetic properties, are not easy to detect and, many times, the use of club drugs is under diagnosed. Although the use of these drugs is increasingly common, few health professionals feel comfortable with the diagnosis and treatment. The authors performed a systematic literature review, with the goal of synthesising the existing knowledge about club drugs, namely epidemiology, mechanism of action, detection, adverse reactions and treatment. The purpose of this article is creating in Portuguese language a knowledge data base on club drugs, that health professionals of various specialties can use as a reference when dealing with individual with this kind of drug abuse.
- 29 December 2011
- Vol. 24 (5) , 739-56
[Club drugs].
Club drugs are the following substances: Methylenedioxymethamphetamine (MDMA); Methamphetamine; Lysergic Acid Diethylamide (LSD); Ketamine; Gamma-hydroxybutyrate (GHB) and Flunitrazepam. These substances are mainly used by adolescents and young adults, mostly in recreational settings like dance clubs and rave parties. These drugs have diverse psychotropic effects, are associated with several degrees of toxicity, dependence and long term adverse effects. Some have been used for several decades, while others are relatively recent substances of abuse. They have distinct pharmacodynamic and pharmacokinetic properties, are not easy to detect and, many times, the use of club drugs is under diagnosed. Although the use of these drugs is increasingly common, few health professionals feel comfortable with the diagnosis and treatment. The authors performed a systematic literature review, with the goal of synthesising the existing knowledge about club drugs, namely epidemiology, mechanism of action, detection, adverse reactions and treatment. The purpose of this article is creating in Portuguese language a knowledge data base on club drugs, that health professionals of various specialties can use as a reference when dealing with individual with this kind of drug abuse.